Clin Endosc.  2020 Jan;53(1):5-6. 10.5946/ce.2020.004.

Endoscopic Retrograde Cholangiopancreatography in Recurrent Acute Pancreatitis: Determining the Optimal Subgroup of Patients in Whom the Procedure is Beneficial

• Lee TY
• Iwashita T

• KMID: 2500898
• DOI: http://doi.org/10.5946/ce.2020.004

Reference

1. Reichstein JB, Patel V, Mekaroonkamol P, et al. Practice patterns and use of endoscopic retrograde cholangiopancreatography in the management of recurrent acute pancreatitis. Clin Endosc. 2020; 53:73–81.

2. Guda NM, Muddana V, Whitcomb DC, et al. Recurrent acute pancreatitis: international state-of-the-science conference with recommendations. Pancreas. 2018; 47:653–666.

3. Wehrmann T. Long-term results (≥ 10 years) of endoscopic therapy for sphincter of Oddi dysfunction in patients with acute recurrent pancreatitis. Endoscopy. 2011; 43:202–207.

4. Bertin C, Pelletier AL, Vullierme MP, et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am J Gastroenterol. 2012; 107:311–317.

5. Lans JI, Geenen JE, Johanson JF, Hogan WJ. Endoscopic therapy in patients with pancreas divisum and acute pancreatitis: a prospective, randomized, controlled clinical trial. Gastrointest Endosc. 1992; 38:430–434.

6. Mariani A, Di Leo M, Petrone MC, et al. Outcome of endotherapy for pancreas divisum in patients with acute recurrent pancreatitis. World J Gastroenterol. 2014; 20:17468–17475.

7. Coté GA, Imperiale TF, Schmidt SE, et al. Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis. Gastroenterology. 2012; 143:1502–1509. e1.